Intracranial nontraumatic haemorrhage of fetus and newborn

P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P52 Cause of death: ICD-10 — P52 2 out of 7 registries used, show all original rules.	50
4. Check minimum number of events None	50
5. Include endpoints None	50
6. Filter based on genotype QC (FinnGen only)	50

Control definitions (FinnGen only)

Control exclude: P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P[5-6]
Name in latin: Haemorrhagia intracranialis non traumatica fetus sive neonati

NAME	P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO
CONTROL_EXCLUDE	P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P52
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P52
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Intracranial nontraumatic haemorrhage of fetus and newborn based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2780	1110	1670
Only index persons	1118	439	679
Unadjusted period prevalence (%)
Whole population	0.04	0.03	0.05
Only index persons	0.02	0.02	0.03
Median age at first event (years)
Whole population	-	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	50	28	22
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	0.00	0.00	0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

12.25

8.94

4.2

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

6.86

6.65

4.4

8.4

651.3

341.6

mg/l

0.64

(3044290) Cell count panel - Cerebral spinal fluid

6.43

5.82

4.8

8.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

10.66

5.02

3.7

1.2

—

(3023410) Appearance of Cerebral spinal fluid

5.70

4.76

4.8

8.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4.23

4.63

2.6

1.2

100.1

101.4

pmol/l

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

5.43

4.53

4.5

8.4

2.7

3.3

mmol/l

—

(3022313) Gas panel - Capillary blood

125

3.25

4.04

27.5

9.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4.04

3.95

2.9

2.0

713.5

204.6

u/l

0.85

(3023368) Bacteria identified in Blood by Culture

3.46

3.92

7.8

4.7

—

(3020393) Adenovirus Ag [Presence] in Stool

7.09

3.66

2.3

2.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

140

3.02

3.58

28.4

9.1

1.2

1.0

mmol/l

0.22

105

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

134

2.96

3.46

28.8

9.0

23.7

24.2

mmol/l

0.35

134

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

9.52

3.36

2.5

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

6.12

3.34

3.4

2.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

7.19

3.30

1.3

9.4

104.7

84.8

—

(3016018) Differential panel - Cerebral spinal fluid

5.73

3.20

4.4

7.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

8.32

3.14

2.5

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

8.32

3.14

2.7

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

6.58

3.14

1.0

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3.54

3.11

5.3

12.6

2.1

2.7

g/l

1.39

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

5.38

3.06

3.4

2.4

—

(44790049)

4.75

3.05

1.8

2.4

—

(44790048)

4.75

3.05

1.8

2.4

—

(44790047)

4.75

3.05

1.8

2.4

—

(44806118)

4.75

3.05

1.8

2.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3.44

2.99

5.5

11.8

101.8

167.1

4.17

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

6.06

2.98

1.9

2.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

4.53

2.94

2.4

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

4.53

2.94

3.3

2.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

4.53

2.94

2.4

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

5.07

2.93

3.9

2.4

—

(3042936) Bacteria identified in Isolate by Culture

3.53

2.90

2.4

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

4.33

2.83

3.3

2.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

9.07

2.81

4.0

10.2

21.0

10.5

mg/l

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

9.07

2.81

1.2

1.8

67.4

91.2

—

(42870588) Differential panel, method unspecified - Blood

212

2.64

12.5

14.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

6.02

2.62

4.0

4.5

1.4

umol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

7.77

2.61

1.2

1.3

—

(3022229) Phosphate [Moles/volume] in Urine

7.77

2.61

3.2

5.6

21.3

13.8

mmol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3.43

2.58

2.4

1.3

—

(3013512) EKG study

3.83

2.54

1.7

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.84

2.36

3.5

2.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

6.02

2.27

5.2

3.4

476.2

415.4

umol/l

—

(3000494) Fungus identified in Specimen by Culture

3.31

2.20

1.9

1.5

—

(3018133) Calcium [Moles/volume] in Urine

5.41

2.12

4.4

4.3

4.2

2.6

mmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

2.40

2.10

4.8

4.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.63

2.05

3.3

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

3.00

1.98

1.1

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.72

1.94

3.5

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.72

1.94

3.6

2.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

107

2.25

1.89

3.1

4.9

2.5

2.6

mg/l

0.09

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.30

1.81

4.1

4.5

—

(40758558) Short blood count panel - Blood

170

2.10

1.76

10.3

12.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.44

1.72

2.0

1.5

—

(3013115) Eosinophils [#/volume] in Blood

269

2.21

1.69

12.8

13.7

0.2

e9/l

0.31

216

(3000991) Gas panel - Venous blood

121

2.09

1.63

11.8

12.8

—

(1761868) Lipid panel - Serum or Plasma

2.69

1.62

2.1

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.58

1.56

2.2

1.6

—

(3022145) Colonoscopy Study observation

3.58

1.56

1.2

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2.64

1.45

1.3

2.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.64

1.45

1.3

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.23

1.42

1.4

1.9

—

(3024731) MCV [Entitic volume]

463

+∞

1.41

32.6

17.7

86.0

84.7

0.88

457

(3035941) MCH [Entitic mass]

463

+∞

1.41

32.6

17.7

29.1

28.5

0.99

457

(3000963) Hemoglobin [Mass/volume] in Blood

463

+∞

1.41

33.4

18.0

132.3

129.1

g/l

0.56

457

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.15

1.39

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

3.15

1.39

2.0

1.6

—

(3044889) 12 lead EKG panel

119

1.96

1.38

2.1

1.7

—

(4035726)

2.97

1.31

2.0

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

203

1.86

1.29

1.9

2.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.81

1.24

3.8

5.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

2.81

1.24

3.8

5.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

226

1.82

1.19

9.2

4.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

151

1.82

1.19

3.6

2.8

0.9

1.1

mmol/l

1.91

143

(1175426) CD3 cells/100 lymphocytes in Blood

2.66

1.18

3.8

5.3

64.4

69.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2.66

1.18

1.2

3.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

135

1.80

1.13

5.0

4.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

155

1.75

1.07

12.6

5.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2.06

1.05

3.6

5.0

11.1

7.6

g/l

—

(3001604) Monocytes [#/volume] in Blood

265

1.72

0.97

12.6

12.3

0.5

0.6

e9/l

0.69

205

(3006315) Basophils [#/volume] in Blood

265

1.72

0.97

12.6

12.3

0.0

e9/l

0.21

205

(3030467) Casts [#/volume] in Urine by Automated count

141

1.70

0.95

13.6

5.3

1.1

0.1

e6/l

0.44

104

(3026008) Bacteria identified in Urine by Culture

1.80

0.94

9.5

3.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

217

1.66

0.93

10.8

4.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

403

2.16

0.90

25.6

11.7

29.2

25.3

mg/l

0.24

271

(40768797) Stomach Pathology biopsy report

2.06

0.87

1.7

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

162

1.64

0.87

39.4

16.8

25.1

24.7

mmol/l

0.29

162

(3019198) Lymphocytes [#/volume] in Blood

270

1.65

0.86

12.7

12.2

2.3

2.8

e9/l

1.04

219

(3013650) Neutrophils [#/volume] in Blood by Automated count

281

1.66

0.84

14.0

14.2

2.7

3.4

e9/l

1.29

223

(3021589) Normoblasts [#/volume] in Blood

272

1.63

0.81

14.8

13.5

0.0

0.1

e9/l

0.46

193

(3024354) Oxygen [Partial pressure] in Venous blood

128

1.63

0.81

12.1

14.0

5.1

5.3

kpa

0.20

128

(3002582) Erythrocytes [#/volume] in Urine

149

1.57

0.74

13.6

5.1

16.6

55.0

e6/l

0.90

111

(3018095) Leukocytes [#/volume] in Urine

168

1.55

0.73

15.2

6.1

90.5

25.2

e6/l

0.39

112

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.02

0.73

6.0

2.3

—

(36304419) Bacteria [Presence] in Urine

142

1.55

0.68

14.1

5.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.69

0.68

3.7

22.4

107.7

105.8

mmol/l

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.62

0.0

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1.81

0.60

1.2

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

128

1.50

0.58

11.3

12.5

24.2

23.3

mmol/l

1.13

120

(3011397) Hemoglobin [Presence] in Urine by Test strip

102

1.52

0.55

4.8

3.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.62

0.54

10.0

4.1

—

(3015736) pH of Urine

121

1.47

0.53

5.1

3.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1.40

0.43

11.9

2.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.42

0.0

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.42

0.0

8.1

—

0.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.4

—

4.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

2.4

—

7.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.42

0.41

1.0

1.1

—

(40768804) Tissue Pathology biopsy report

1.42

0.41

1.9

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.42

0.41

8.7

5.2

1.9

1.6

e6/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.40

0.0

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

150

1.31

0.32

3.7

2.9

32.7

35.7

mmol/mol

0.89

136

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.32

0.31

1.1

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.30

0.28

1.6

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.31

0.26

9.2

5.5

1.5

0.5

e6/l

—

(36660697) Celiac disease serology panel - Serum

101

0.75

0.24

1.0

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1.21

0.22

6.6

4.6

15.4

20.9

nmol/l

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.00

0.21

0.0

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

36.4

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3000330) Specific gravity of Urine by Test strip

0.00

0.21

0.0

1.4

—

(3024932) HLA-DR beta [Type]

0.00

0.21

0.0

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3024471) HLA-A [Type]

0.00

0.21

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

0.21

0.0

44.0

—

11.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

0.00

0.21

0.0

1.6

—

0.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.20

0.0

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.17

0.20

2.2

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1.25

0.18

9.4

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.25

0.18

1.7

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.19

0.16

1.9

2.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

242

1.15

0.13

5.1

4.7

7.0

8.4

mm/h

0.33

222

(3003694) ABO and Rh group [Type] in Blood

134

1.17

0.12

1.8

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.12

0.07

2.1

2.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

415

0.93

0.07

4.1

3.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

141

0.89

0.06

2.8

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

201

0.91

0.06

2.1

1.8

1.6

1.3

g/l

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

0.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.0

7.5

—

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

5.2

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.0

1.5

—

(3042733) HLA Ab [Presence] in Serum

0.00

0.0

2.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.0

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

175.7

—

(3045414) Leukocytes [Presence] in Urine

0.00

0.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.0

1.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

3.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.00

0.00

2.2

2.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

0.00

0.0

2.1

—

67.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.0

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

0.00

0.0

1.4

—

2.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.86

0.00

2.0

1.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.0

1.0

—

112.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.0

1.4

—

(4062490)

0.00

0.0

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

0.00

0.0

1.4

—

5.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

3.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

10.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO – Intracranial nontraumatic haemorrhage of fetus and newborn

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Intracranial nontraumatic haemorrhage of fetus and newborn

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints